Martin D. Madaus
Sits on 5 boards. Overboarded · 5 public boards Last updated September 27, 2026
Time on boards
- Boards served
- 5
- Current seats
- 5
- Board service
- 14 years
- Director since
- 2023
14 years of board service in total across 5 boards, counting each seat separately. Longest: Quanterix Corporation, 3 years.
Quanterix Corporation
Director
Repligen Corporation
Director
Standard BioTools Inc.
Director
Azenta Inc.
Director
Haemonetics Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | Azenta Inc. | Shares withheld for tax | −1,456 | $34.28 | $49,912 |
| Sep 14, 2026 | Azenta Inc. | Grant or award | +36,653 | — | — |
| Jul 24, 2026 | Haemonetics Corporation | Grant or award | +2,538 | — | — |
| May 14, 2026 | Repligen Corporation | Grant or award | +995 | — | — |
| Aug 8, 2025 | Repligen Corporation | Open-market purchase | +1,800 | $112.13 | $201,834 |
| May 15, 2025 | Repligen Corporation | Grant or award | +973 | — | — |
| Jan 2, 2025 | Quanterix Corporation | Grant or award | +7,435 | — | — |
| Nov 19, 2024 | Azenta Inc. | Open-market purchase | +4,940 | $40.77 | $201,404 |
| Jun 14, 2024 | Repligen Corporation | Open-market purchase | +915 | $124.54 | $113,954 |
| Jun 14, 2024 | Repligen Corporation | Open-market purchase | +700 | $125.46 | $87,822 |
| May 16, 2024 | Repligen Corporation | Grant or award | +701 | — | — |
| Feb 12, 2024 | Azenta Inc. | Grant or award | +2,465 | $65.93 | $162,517 |
| Jan 2, 2024 | Quanterix Corporation | Grant or award | +2,947 | — | — |
| Oct 20, 2023 | Standard BioTools Inc. | Grant or award | +1,574 | $2.54 | $3,998 |
| Jun 14, 2023 | Standard BioTools Inc. | Grant or award | +26,376 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.